Yichang Humanwell Pharmaceutical Co.,Ltd Report issue

For profit Phase 4
Founded: Hubei China (1954)
Status: No NME R&D (1954)

Organization Overview

First Clinical Trial
2015
NCT02635802
First Marketed Drug
2016
ibuprofen (motrin)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

HUMANWELL PHARMACEUTICAL US INC | HUMANWELL PURACAP | YICHANG HUMANWELL | Yichang Humanwell Pharmaceutical Co.,Ltd | Yichang Humanwell Pharmaceutical Co., Ltd., China